Ultrasound signal enhancement

Ultrasound signal enhancement is a diagnostic phenomenon rather than a biological molecule or therapeutic target. It refers to the process of increasing the visibility of blood vessels and organ perfusion during an ultrasound examination, primarily through the use of exogenous ultrasound contrast agents (UCAs). These agents consist of microscopic gas bubbles, such as sulfur hexafluoride or perfluorocarbons, encapsulated within a stabilizing shell of lipids or proteins. When these microbubbles are exposed to ultrasound, they undergo stable or inertial cavitation, scattering the acoustic energy and providing a high-contrast signal relative to the background tissue. This technique, known as contrast-enhanced ultrasound (CEUS), is widely utilized in clinical practice to characterize focal liver lesions, assess myocardial viability, and monitor blood flow in real-time. Because the enhancement is a physical result of the interaction between sound waves and contrast media, it does not involve a specific endogenous receptor or signaling pathway.

Other names

Contrast-enhanced ultrasoundCEUSAcoustic signal enhancementUltrasound contrast enhancement

Ultrasound signal enhancement is achieved through the administration of ultrasound contrast agents (UCAs), typically gas-filled microbubbles. These microbubbles oscillate in response to ultrasound waves, creating a high acoustic impedance mismatch with surrounding blood and tissue, which significantly increases the backscattered signal (echogenicity).